Hippo pathway mediates resistance to cytotoxic drugs

Taranjit S. Gujral,Marc W. Kirschner

DOI: https://doi.org/10.1073/pnas.1703096114

IF: 11.1

2017-04-17

Proceedings of the National Academy of Sciences

Abstract:Significance Cytotoxic therapy is still the backbone of effective chemotherapy, although most current pharmaceutical interest is in targeted therapy. Our findings concern a general adaptive response of cells that causes resistance to gemcitabine and 15 other FDA-approved cytotoxic drugs when cells are grown at high density. Although on the surface cell confluence seems like it could be an irrelevant property of cells in culture, our work shows that it is very relevant to tumors in mice and retrospectively to the success of chemotherapy in humans. On a fundamental cell biological level, these studies identify a previously unappreciated function of the enigmatic Hippo pathway, which controls this response. “Switching-off” this pathway could present an opportunity to overcome drug resistance in pancreatic cancer.